Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02084797 · ClinicalTrials.gov registry record · NA
V2 Receptor Effects on Fluid Regulation and Performance
A NA study, sponsored by Oakland University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02084797 is a NA study that has completed, run by Oakland University. The registered enrollment target is 10 participants.
The verdict
NCT02084797, a NA study, has completed, sponsored by Oakland University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This primary aim of this study was to critically assess whether or not sweat water content and sodium concentration were acutely regulated by dynamic changes in antidiuretic hormone (arginine vasopressin or AVP) acting on the Vasopressin 2 receptor (V2R) during exercise. Secondary aims were to evaluate running performance and core temperature to further characterize the role of AVP in the coordinated balance of fluid and temperature homeostasis during exercise. The primary hypothesis was that activation of the V2R in sweat glands would result in water reabsorption and fluid conservation during endurance exercise.
Interventions
- DRUG V2R (Vasopressin 2 receptor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02084797
The ClinicalTrials.gov registry entry for NCT02084797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oakland University, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which V2R (Vasopressin 2 receptor) is the first listed.
NCT02084797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02084797 about?
NCT02084797 is a clinical study titled "V2 Receptor Effects on Fluid Regulation and Performance". This primary aim of this study was to critically assess whether or not sweat water content and sodium concentration were acutely regulated by dynamic changes in antidiuretic hormone (arginine vasopressin or AVP) acting on the Vasopressin 2 receptor (V2R) during exercise. Secondary aims were to evalu...
What is the current status of trial NCT02084797?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2011-06. Estimated completion is 2012-10.
What interventions are being tested in trial NCT02084797?
The interventions under investigation include: V2R (Vasopressin 2 receptor) (DRUG).
Who is sponsoring clinical trial NCT02084797?
This trial is sponsored by Oakland University, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.